Followers | 145 |
Posts | 27561 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Thursday, November 10, 2005 12:41:01 PM
10.11.2005 | 17:03
Omri Cohen
Itzick Sharir today ends a five-year stint as president and CEO of Sapiens International (Nasdaq:SPNS), which today published third-quarter results that should put a damper on any toasts.
The North Carolina-based Israeli-American firm, which develops software for financing houses, recorded revenues of $9.9 million, up 3% from the $9.6 million posted for the previous quarter. But against the parallel quarter, revenue fell 13%.
Gross profit also slipped against the parallel quarter, by 22%, to $3.8 million or 38% of turnover.
Its operating loss quintupled to $942,000, even though marketing costs were trimmed by 14% to $3.6 million.
Sapiens stock in the last year
Roni Al-Dor will assume today the position of President and CEO, replacing Itzick Sharir who served Sapiens for the last five years. Mr. Al-Dor also joins the company's Board of Directors as a new additional member. Net loss for the third quarter contracted to $1.6 million, versus a net loss of $1.7 million in the second quarter of 2005, an improvement of 6%. But in the parallel quarter of 2004 it had lost a lesser $954,000 in net terms.
On his last day Sharir chose to address the improvement against the second quarter, not dwell on the slide against the parallel. "Although still losing, we see for the first time a significant improvement of 50% over the previous quarter in new signed contracts, a small change for the better in our top-line, and a significant continued reduction of 30% over the previous quarter in our operational losses," he said, in his requiem to investors.
"I personally believe that this is the beginning of a change in trend, where hopefully the worse is behind us and the quarters to come will continue to improve," he added.
Sharir welcomed Roni Al-Dor as the new president and CEO with the hope and belief "that he will continue the mission and lead Sapiens back to success and prosperity."
From the start of 2005, Sapiens' sales have slid 17% against the same period of 2004 to $29.6 million, while its net loss soared 74% to $6 million, or 51 cents per share.
In nine months Sapiens burned up $9 million and is left, at the end of September, with $13.25 million. It owes the banks $13.6 million.
This year Sapiens stock fell 39%, dropping to $1.74 per share last night on Nasdaq, which depressed the company's market capitalization to $20.6 million.
http://www.themarker.com/eng/article.jhtml?ElementId=%2Fibo%2Frepositories%2Fstories%2Fm1_2000%2Foc2...
Dubi
Recent SPNS News
- Sapiens to Participate in the Needham Technology, Media, & Consumer Conference on May 15, 2024 • PR Newswire (US) • 05/01/2024 11:55:00 AM
- Sapiens Unveils Enhanced Reinsurance and Analytics Solution Catering to Evolving Market Demands • PR Newswire (US) • 04/25/2024 10:28:00 AM
- Sapiens Unveils Enhanced Reinsurance and Analytics Solution Catering to Evolving Market Demands • PR Newswire (US) • 04/25/2024 10:24:00 AM
- SAPIENS TO ANNOUNCE FIRST QUARTER OF 2024 FINANCIAL RESULTS ON MAY 8, 2024 • PR Newswire (US) • 04/24/2024 10:22:00 AM
- Sapiens Launches IntegrateAI, the Second Release in its DecisionAI Portfolio • PR Newswire (US) • 04/18/2024 12:32:00 PM
- Sapiens Launches IntegrateAI, the Second Release in its DecisionAI Portfolio • PR Newswire (US) • 04/18/2024 12:31:00 PM
- Sapiens Files Annual Report on Form 20-F for the Year Ended December 31, 2023 • PR Newswire (US) • 03/26/2024 01:25:00 PM
- SAPIENS DECLARES CASH DIVIDEND OF $15.6 MILLION, OR $0.28 PER SHARE FOR THE SECOND HALF OF 2023 • PR Newswire (US) • 03/25/2024 11:00:00 AM
- Celent Names Sapiens P&C Claims Solution as 2024 Luminary in EMEA and APAC • PR Newswire (US) • 03/21/2024 12:22:00 PM
- Celent Names Sapiens P&C Claims Solution as 2024 Luminary in EMEA and APAC • PR Newswire (US) • 03/21/2024 12:20:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/11/2024 01:53:34 PM
- Celent Names Sapiens ClaimsPro for P&C in North America as 2024 Luminary • PR Newswire (US) • 03/11/2024 01:48:00 PM
- Celent Names Sapiens ClaimsPro for P&C in North America as 2024 Luminary • PR Newswire (US) • 03/11/2024 01:45:00 PM
- Sapiens Expands Presence in Canadian Market to Accelerate Growth for Canadian Insurers • PR Newswire (US) • 03/04/2024 01:46:00 PM
- Sapiens étend sa présence sur le marché canadien pour accélérer la croissance des assureurs canadiens • PR Newswire (Canada) • 03/04/2024 01:42:00 PM
- Sapiens Expands Presence in Canadian Market to Accelerate Growth for Canadian Insurers • PR Newswire (Canada) • 03/04/2024 01:37:00 PM
- Sapiens Expands Presence in Canadian Market to Accelerate Growth for Canadian Insurers • PR Newswire (US) • 03/04/2024 01:32:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2024 01:30:27 PM
- Sapiens Expands Presence in Canadian Market to Accelerate Growth for Canadian Insurers • PR Newswire (US) • 03/04/2024 01:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 01:25:23 PM
- Sapiens and DataCrest Forge Partnership to Elevate Underwriting Precision in P&C Sector • PR Newswire (US) • 02/26/2024 01:25:00 PM
- Sapiens and DataCrest Forge Partnership to Elevate Underwriting Precision in P&C Sector • PR Newswire (US) • 02/26/2024 01:25:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 11:22:10 AM
- UK Insurer BHSF Selects Sapiens SaaS Platform for Digital Transformation and Enhanced Customer Experiences • PR Newswire (US) • 02/21/2024 01:27:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/21/2024 01:25:03 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM